gene profiling study for the efficacy of Trastuzumab
Not Applicable
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000002325
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients with brain metastasis 2. patients with massive effusion 3. patinets with sever heart failure and reduced cardiac function caused treatment with trastuzumab 4. patients with pregnancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method repeatability investigation
- Secondary Outcome Measures
Name Time Method